Search

everythinglearnresearchcommunity

for

Search:↓

Scalp psoriasis is hard to treat and may need various medications.

Different treatments for skin conditions were found to be effective and generally safe, with biologics recommended as the first choice for generalized pustular psoriasis.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

A woman's severe hair loss was caused by scalp psoriasis, not the initially thought condition, and treatment improved her psoriasis but couldn't restore her lost hair.

Fox Fordyce disease might be more common in prepubertal girls than thought and can be managed with treatment.

Etretinate was effective for certain skin conditions, but caused side effects like chapped lips, dry mucous membranes, and hair loss.

Smoking and certain health conditions like thyroid disease may make palmoplantar pustulosis harder to treat.

New treatments for hair growth and psoriasis may be possible, and gene differences could affect baldness and the severity of skin conditions.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Methotrexate effectively treated a 2-year-old's generalized pustular psoriasis without side effects.

A woman with long-term scalp psoriasis developed rare scarring hair loss that didn't fully respond to treatments.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Healthy hair and scalp depend on overall body health.

Effective treatments for scalp psoriasis include glucocorticosteroids, Vitamin D3 analogs, and combination therapies like calcipotriol and betamethasone dipropionate.

Alefacept may effectively treat severe lichen planus, with patients showing significant improvement and no side effects.

Secukinumab for psoriasis unexpectedly caused increased hair growth in a patient.

New treatments for skin conditions like psoriasis, acne, and eczema were introduced.

The symposium highlighted the importance of understanding disease mechanisms for targeted dermatology treatments.

A new side effect of aromatic retinoid treatment is soft nails.

A woman's hair grew back after stopping acitretin for psoriasis and getting steroid treatment, and low vitamin D might be linked to alopecia severity.

Minoxidil improves quality of life for women with hair loss.

Combining conventional and Chinese herbal medicine could help treat some skin and hormone-related diseases.

Fullerene C60 shows promise as a new treatment for various skin conditions.

New gene mutations linked to skin conditions were found, bacteria and chemicals may worsen acne, a dog mutation could exist in humans, virus-like elements might be involved in psoriasis, and a vitamin D3 treatment doesn't prevent chemotherapy-related hair loss.

The S100A4 protein is more common in psoriatic skin and could be a target for treating psoriasis.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Patients with psoriasis and cutaneous-oral lichen planus have higher blood homocysteine levels than healthy people.

Hair transplantation can be safe for well-controlled, stable psoriasis patients with proper care.